Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12).
“Omeprazole therapy acutely decreased cyanocobalamin absorption in a dose-dependent manner.”
Names both Omeprazole and Vitamin B12 in its title.
Supplement × Prescription·Evidence index
PubMed indexes 8 records that name Omeprazole and Vitamin B12 together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.
Every statement below is attributed to a named, dated, linked source.
This page lists published research relevant to Omeprazole and Vitamin B12. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.
Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.
“Omeprazole therapy acutely decreased cyanocobalamin absorption in a dose-dependent manner.”
Names both Omeprazole and Vitamin B12 in its title.
“Omeprazole causes protein-bound vitamin B12 malabsorption, and ingestion of an acidic drink improves protein-bound vitamin B12 absorption.”
Names both Omeprazole and Vitamin B12 in its title.
“Long-term use of omeprazole is suggested to induce an oxidative stress condition, which causes neurotoxicity and cognitive decline.”
Names both Omeprazole and Vitamin B12 in its title.
“All healthcare workers should be made aware of the potential clinical complications of omeprazole-associated vitamin B12 deficiency since it may go unrecognized and is easily corrected. This is particularly relevant for elderly patients with poor dietary intake of vitamin B12, impaired vitamin B12 stores, and certain gastrointestinal disorders.”
Names both Omeprazole and Vitamin B12 in its title.
“The development of atrophic gastritis during omeprazole treatment in H. pylori-positive GERD patients is associated with a decrease of serum vitamin B12 levels.”
Names both Omeprazole and Vitamin B12 in its title.
“CYP2C19 polymorphism significantly affected serum vitamin B12 levels in patients on long-term therapy with omeprazole. In the future, genotyping of CYP2C19 may be useful for patients in need of long-term treatment with omeprazole or other proton pump inhibitors.”
Names both Omeprazole and Vitamin B12 in its title.
Names both Omeprazole and Vitamin B12 in its title.
Names both Omeprazole and Vitamin B12 in its title.
Search-based evidence indexes have real limits, and it is worth being explicit about them:
NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Omeprazole, Vitamin B12, and several hundred other substances.
The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.